Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Hair loss linked to higher heart disease risk in both men and women.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Certain genes may influence hair loss differently in men and women.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Stress worsens hair loss in androgenetic alopecia.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Hair from balding and non-balding areas regrows similarly on mice.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Apoptosis contributes to hair loss in androgenetic alopecia.

Low-level laser therapy improves hair growth and dermal papilla cell function.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Early onset hair loss linked to genetics and androgen levels.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).